Adracalin anticorps
Aperçu rapide pour Adracalin anticorps (ABIN7111183)
Antigène
Voir toutes Adracalin (AAAS) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Fonction
- AAAS antibody
-
Purification
- Immunogen affinity purified
-
Pureté
- ≥95 % as determined by SDS-PAGE
-
Immunogène
- achalasia, adrenocortical insufficiency, alacrimia (Allgrove, triple-A)
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB: 1:500 - 1:2000, IHC: 1:50 - 1:200, IF: 1:50 - 1:200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freeze / thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C for 12 months
-
Date de péremption
- 12 months
-
-
- Adracalin (AAAS) (Achalasia, Adrenocortical Insufficiency, Alacrimia (AAAS))
-
Autre désignation
- AAAS
-
Sujet
-
Synonyms: Aladin|Adracalin|AAAS|ADRACALA
Background: The protein encoded by this gene is a member of the WD-repeat family of regulatory proteins and may be involved in normal development of the peripheral and central nervous system. The encoded protein is part of the nuclear pore complex and is anchored there by NDC1. Defects in this gene are a cause of achalasia-addisonianism-alacrima syndrome (AAAS), also called triple-A syndrome or Allgrove syndrome. Two transcript variants encoding different isoforms have been found for this gene.
-
Poids moléculaire
- 60 kDa
-
ID gène
- 8086
-
UniProt
- Q9NRG9
Antigène
-